A Multicenter, Randomized, Double-blind, Placebo Controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy Using Two Different Titration Schemes.

Trial Profile

A Multicenter, Randomized, Double-blind, Placebo Controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy Using Two Different Titration Schemes.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2015

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 25 Apr 2015 Results of pooled and subgroup analysis presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 15 Sep 2009 UCB added as trial sponsor as reorted by ClinicalTrials.gov.
    • 18 Aug 2008 Results presented at the 12th World Congress on Pain, Aug, 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top